Journal article
A new polygenic score for refractive error improves detection of children at risk of high myopia but not the prediction of those at risk of myopic macular degeneration
- Abstract:
-
Background
High myopia (HM), defined as a spherical equivalent refractive error (SER) ≤ -6.00 diopters (D), is a leading cause of sight impairment, through myopic macular degeneration (MMD). We aimed to derive an improved polygenic score (PGS) for predicting children at risk of HM and to test if a PGS is predictive of MMD after accounting for SER.
Methods
The PGS was derived from genome-wide association studies in participants of UK Biobank, CREAM Consortium, and Genetic Epidemiology Research on Adult Health and Aging. MMD severity was quantified by a deep learning algorithm. Prediction of HM was quantified as the area under the receiver operating curve (AUROC). Prediction of severe MMD was assessed by logistic regression.
Findings
In independent samples of European, African, South Asian and East Asian ancestry, the PGS explained 19% (95% confidence interval 17-21%), 2% (1-3%), 8% (7-10%) and 6% (3-9%) of the variation in SER, respectively. The AUROC for HM in these samples was 0.78 (0.75-0.81), 0.58 (0.53-0.64), 0.71 (0.69-0.74) and 0.67 (0.62-0.72), respectively. The PGS was not associated with the risk of MMD after accounting for SER: OR = 1.07 (0.92-1.24).
Interpretation
Performance of the PGS approached the level required for clinical utility in Europeans but not in other ancestries. A PGS for refractive error was not predictive of MMD risk once SER was accounted for.
Funding
Supported by the Welsh Government and Fight for Sight (24WG201).
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Supplementary materials, pdf, 410.2KB, Terms of use)
-
(Preview, Version of record, pdf, 2.3MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.ebiom.2023.104551
Authors
Contributors
+ CREAM Consortium
- Role:
- Contributor
+ UK Biobank Eye and Vision Consortium
- Role:
- Contributor
+ Allen, N
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Nuffield Department of Population Health
- Sub department:
- Clinical Trial Service Unit
- Role:
- Contributor
+ Gallacher, J
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Psychiatry
- Role:
- Contributor
+ Welsh Government
More from this funder
- Funder identifier:
- https://ror.org/000wh6t45
- Grant:
- 24WG201
- Programme:
- co-supported with Fight for Sight
+ Medical Research Council
More from this funder
- Funder identifier:
- https://ror.org/03x94j517
- Grant:
- MC_PC_19009
- MR/T033371/1
- MC_PC_15018
+ European Research Council
More from this funder
- Funder identifier:
- https://ror.org/0472cxd90
- Grant:
- 648268
- Publisher:
- Elsevier
- Journal:
- EBioMedicine More from this journal
- Volume:
- 91
- Article number:
- 104551
- Place of publication:
- Netherlands
- Publication date:
- 2023-04-11
- Acceptance date:
- 2023-03-17
- DOI:
- EISSN:
-
2352-3964
- Pmid:
-
37055258
- Language:
-
English
- Keywords:
- Pubs id:
-
1340439
- Local pid:
-
pubs:1340439
- Deposit date:
-
2025-06-25
- ARK identifier:
Terms of use
- Copyright holder:
- Clark et al.
- Copyright date:
- 2023
- Rights statement:
- © 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record